A detailed history of Hemington Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Hemington Wealth Management holds 582 shares of EW stock, worth $45,396. This represents 0.01% of its overall portfolio holdings.

Number of Shares
582
Previous 525 10.86%
Holding current value
$45,396
Previous $38,000 10.53%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

BUY
$67.95 - $76.19 $3,873 - $4,342
57 Added 10.86%
582 $42,000
Q4 2024

Jan 29, 2025

BUY
$64.54 - $75.92 $3,420 - $4,023
53 Added 11.23%
525 $38,000
Q3 2024

Nov 12, 2024

BUY
$59.7 - $93.78 $28,178 - $44,264
472 New
472 $31,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $48.2B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.